Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KB1 | P23443 | 5/20 | 0.43 |
| ▸ | AURKB | Q96GD4 | 5/20 | 0.43 |
| ▸ | KDR | P35968 | 4/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 4/20 | 0.43 |
| ▸ | CHEK2 | O96017 | 4/20 | 0.43 |
| ▸ | PRKACA | P17612 | 4/20 | 0.43 |
| ▸ | AKT1 | P31749 | 4/20 | 0.43 |
| ▸ | GSK3B | P49841 | 4/20 | 0.43 |
| ▸ | RPS6KA3 | P51812 | 4/20 | 0.43 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.43 |
| ▸ | PRKG1 | Q13976 | 4/20 | 0.43 |
| ▸ | PKN2 | Q16513 | 4/20 | 0.43 |
| ▸ | CDC42BPA | Q5VT25 | 4/20 | 0.43 |
| ▸ | HIPK4 | Q8NE63 | 4/20 | 0.43 |
| ▸ | CHEK1 | O14757 | 3/20 | 0.43 |
| ▸ | AKT2 | P31751 | 3/20 | 0.43 |
| ▸ | CLK2 | P49760 | 3/20 | 0.43 |
| ▸ | PRKAA1 | Q13131 | 3/20 | 0.43 |
| ▸ | PRKG2 | Q13237 | 3/20 | 0.43 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4597033 | 0.91 | KDR (0.52) | RPS6KB1AURKBKDRROCK2CHEK2 | |
| SCHEMBL4597203 | 0.81 | KMT2A (0.46) | RPS6KB1AURKBKDRROCK2CHEK2 | |
| SCHEMBL28632683 | 0.79 | PTPN11 (0.46) | KDRMAPKAPK2RIPK2TRPM5RIPK3 | |
| SCHEMBL30513611 | 0.79 | PTPN11 (0.46) | KDRMAPKAPK2RIPK2TRPM5RIPK3 | |
| SCHEMBL4906887 | 0.78 | MAPKAPK2 (0.54) | RPS6KB1AURKBKDRROCK2CHEK2 | |
| SCHEMBL4905587 | 0.78 | ROCK1 (0.48) | RPS6KB1AURKBKDRROCK2CHEK2 | |
| SCHEMBL4597939 | 0.77 | KDR (0.48) | RPS6KB1AURKBKDRROCK2CHEK2 | |
| SCHEMBL4900237 | 0.77 | NPC1 (0.50) | RPS6KB1AURKBKDRROCK2CHEK2 | |
| SCHEMBL4596911 | 0.76 | NAMPT (0.47) | RPS6KB1AURKBKDRROCK2CHEK2 | |
| SCHEMBL4596918 | 0.75 | GSK3B (0.46) | RPS6KB1AURKBKDRROCK2CHEK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080234266-A1 | Squaric Acid Derivatives II | MERCK PATENT GESELLSCHAFT (DE) | 2008-09-25 | — | — | US | claimed |
| EP-1910312-A1 | QUADRATIC ACID II DERIVATIVES | Merck Patent GmbH (DE) | 2008-04-16 | — | — | EP | claimed |
| WO-2007014608-A1 | QUADRATIC ACID II DERIVATIVES | MERCK PATENT GMBH (DE) | 2007-02-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234266-A1 | Squaric Acid Derivatives II | CHEK2, CHEK1, SGK3 | RPS6KB1 304/4885AURKB 67/4885KDR 2703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.